CG Oncology, Inc. (NASDAQ:CGON) Receives Average Recommendation of “Buy” from Analysts
CG Oncology, Inc. (NASDAQ:CGON – Get Free Report) has been assigned a consensus rating of “Buy” from the eight analysts that are covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month target price among […]
More Stories
NextEra Energy (NYSE:NEE) Releases FY24 Earnings Guidance
NextEra Energy (NYSE:NEE – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share...
Contineum Therapeutics (NASDAQ:CTNM) Lifted to “Strong-Buy” at Baird R W
Baird R W upgraded shares of Contineum Therapeutics (NASDAQ:CTNM – Free Report) to a strong-buy rating in a report issued...
Marietta Wealth Management LLC Increases Holdings in NextEra Energy, Inc. (NYSE:NEE)
Marietta Wealth Management LLC increased its position in NextEra Energy, Inc. (NYSE:NEE – Free Report) by 1.8% in the 3rd...
iShares MSCI EAFE ETF (NYSEARCA:EFA) Position Increased by Macroview Investment Management LLC
Macroview Investment Management LLC boosted its stake in shares of iShares MSCI EAFE ETF (NYSEARCA:EFA – Free Report) by 7.4%...
Lecap Asset Management Ltd. Buys Shares of 70,072 Core & Main, Inc. (NYSE:CNM)
Lecap Asset Management Ltd. purchased a new position in shares of Core & Main, Inc. (NYSE:CNM – Free Report) during...
Corundum Trust Company INC Sells 6,000 Shares of Osisko Gold Royalties Ltd (NYSE:OR)
Corundum Trust Company INC lessened its position in shares of Osisko Gold Royalties Ltd (NYSE:OR – Free Report) by 37.5%...